Table 1.
The demographic and clinical features in groups
| Variables | Group I (n = 20) |
Group II (n = 18) |
Group III (n = 20) |
P |
|---|---|---|---|---|
| Age (years) |
25.40 ± 6.43 (14–36) |
25.38 ± 6.96 (16–39) |
23.60 ± 6.56 (17–35) |
0.623* |
| Gender (F/M) | 9F/11M | 9F/9M | 11F/9M | 0.819† |
| IOP (mm/Hg) |
14.95 ± 3.05 (10–19) |
13.83 ± 1.65 (10–16) |
13.55 ± 2.21 (10–17) |
0.161* |
| SE (D) |
−0.07 ± 0.42 (− 0.60–0.51) |
−0.10 ± 0.99 (−1.33–1.34) |
−0.06 ± 0.78 (− 0.67–0.97) |
0.105* |
| Schirmer (mm) |
21.00 ± 5.78 (10–35) |
20.61 ± 7.62 (12–35) |
22.70 ± 7.02 (14–35) |
0.604* |
| BUT (sec) |
12.85 ± 3.23 (10–19) |
12.38 ± 1.61 (11–18) |
13.00 ± 2.33 (10–17) |
0.741* |
| CECD (cell/mm2) |
2599 ± 215 (2258–2895) |
2652 ± 240 (2330–3001) |
2539 ± 227 (2312–2998) |
0.286* |
Group I: Wilson’s disease without Kayser-Fleischer ring; Group II: Wilson’s disease with Kayser-Fleischer ring; Group III: Healthy individuals; F= female; M= male; SE= spherical equivalent; IOP= intraocular pressure; BUT= break-up time; CECD= corneal endothelial cell density; n= number of eyes
*: One-way ANOVA
†: Chi-squared test